Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001199120 | SCV001370115 | uncertain significance | Singleton-Merten syndrome 2 | 2019-07-09 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: No criteria apply. |
Labcorp Genetics |
RCV001859207 | SCV002163378 | uncertain significance | not provided | 2022-06-27 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with DDX58-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 932023). This variant is present in population databases (rs760088776, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Asn133Argfs*15) in the DDX58 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in DDX58 cause disease. |